郑州速达工业机械服务股份有限公司 2025 年年度报告全文 郑州速达工业机械服务股份有限公司 2025 年年度报告 1 郑州速达工业机械服务股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责 任。 公司负责人李锡元、主管会计工作负责人谢立智及会计机构负责人（会 计主管人员）罗小苗声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 公司敬请投资者认真阅读 2025 年年度报告全文，并特别关注公司未来经 营发展中可能存在的风险因素，详细内容见本报告"第三节 管理层讨论与分 析"之"十一、公司未来发展的展望"章节的相关内容，敬请广大投资者注 意投资风险。 公司经本次董事会审议通过的利润分配预案为：以 2025 年 12 月 31 日的 公司总股本 76,000,000 股为基数，向全体股东每 10 股派发现金红利 3.42 元 （含税），送红股 0 股（含税），不以公积金转增股本。 2 | | 1 | ...

Financial Performance - The company's operating revenue for 2025 reached ¥6,670,181,013.25, representing a 14.91% increase compared to ¥5,804,657,336.92 in 2024 [22]. - Net profit attributable to shareholders for 2025 was ¥1,132,569,775.63, up 19.35% from ¥948,950,036.00 in 2024 [22]. - The cash flow from operating activities for 2025 was ¥1,407,585,059.70, reflecting a 12.22% increase from ¥1,254,337,014.51 in 2024 [22]. - Basic earnings per share for 2025 were ¥3.16, a 17.47% increase from ¥2.69 in 2024 [22]. - The net profit after deducting non-recurring gains and losses for 2025 was ¥1,036,509,205.54, which is a 22.01% increase from ¥849,537,214.96 in 2024 [22]. - The company reported a quarterly revenue of ¥2,040,303,882.27 in Q4 2025, contributing to a total annual revenue growth [27]. - The company achieved total revenue of 6.67 billion yuan, a year-on-year increase of 14.91%, with a constant exchange rate growth of 16.78% [34]. - The net profit attributable to shareholders was 1.133 billion yuan, a year-on-year increase of 19.35%, while adjusted net profit was 1.253 billion yuan, up 56.09% [34]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 13 RMB per 10 shares to all shareholders, with no stock bonus [5]. - The total cash dividend amount, including other methods, is RMB 1,046.48 million, which accounts for 100% of the distributable profit of RMB 1,867.60 million [138]. - The cash dividend policy complies with the company's articles of association and shareholder resolutions, ensuring the protection of minority shareholders' rights [137]. - The cash dividend distribution was completed for both A-shares and H-shares within the stipulated time [136]. Revenue Sources and Business Segments - Revenue from large pharmaceutical companies was 2.916 billion yuan, a year-on-year increase of 8.36%, while revenue from small and medium-sized pharmaceutical companies was 3.755 billion yuan, up 20.57% [35]. - The small molecule CDMO business generated revenue of 4.735 billion yuan, a year-on-year increase of 3.59%, with a gross margin of 46.83% [36]. - Emerging business services achieved revenue of 1.929 billion yuan, a year-on-year increase of 57.30%, with overseas revenue exceeding 240% growth [37]. - The chemical macromolecule CDMO business reported revenue of 1.028 billion yuan, a year-on-year increase of 123.72%, with overseas orders accounting for 58.42% [38]. - The biopharmaceutical CDMO business generated revenue of 294 million yuan, a year-on-year increase of 95.76%, with overseas project revenue accounting for 39.55% [40]. - The formulation CDMO business achieved revenue of 284 million yuan, a year-on-year increase of 18.44%, with a total of 200 projects executed [42]. Operational Efficiency and Capacity Expansion - The company plans to increase its production capacity for macromolecule solid-phase synthesis to 69,000L by the end of 2026 to meet future order demands [39]. - Clinical research services revenue reached 282 million yuan, a year-on-year increase of 26.53%, with 216 new projects initiated, including a more than 50% increase in new II/III phase clinical research projects [44]. - The company is currently conducting 294 clinical research projects, with 122 projects in clinical phase II and beyond [44]. - The company achieved a 1000-fold increase in enzyme activity within 4 weeks through new enzyme product development, significantly enhancing R&D efficiency [46]. - The company has established a 500L GMP workshop, successfully delivering 3 IND projects, and has a fully operational fermentation facility covering approximately 17,000 square meters [46]. Research and Development - R&D investment for 2025 is projected at 593 million yuan, accounting for 8.89% of revenue, with a total of 577 authorized patents, including 205 in synthetic biology [48]. - The company has a total of 400 patents authorized both internationally and domestically, showcasing its strong research and development capabilities [110]. - The company is focusing on expanding its capabilities in ADC drug development, addressing key technical bottlenecks in the industry [73]. - The company is actively pursuing new product development and technological advancements to maintain competitive advantage in the biopharmaceutical industry [117]. Market Position and Strategy - The company is a leading global pharmaceutical outsourcing service provider, focusing on drug research and development, and offers one-stop services for large and medium-sized pharmaceutical and biotechnology companies [4]. - The global CDMO market is expected to reach 124.3 billion USD by 2025, with a compound annual growth rate of 13.2% [51]. - The company has formed strong partnerships with major pharmaceutical companies, increasing the penetration rate of global pipelines [53]. - The company is recognized as a leading technology-driven CDMO, providing comprehensive solutions across the drug development and production process [54]. Governance and Compliance - The company has established a clear and independent governance structure, ensuring that the board of directors and management operate independently from the controlling shareholder [99]. - The board of directors consists of three independent directors, meeting the requirement of one-third of the total board members [100]. - The company has implemented a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal regulations [103]. - The company has established a dedicated investor relations management office to oversee communication and engagement with investors [101]. Employee and Management Structure - The company employed 10,617 staff, with 78.2% holding a bachelor's degree or higher, and 38.8% of R&D personnel being senior researchers [49]. - The total number of shares held by Zhang Da, the Chief Operating Officer and CFO, increased from 326,000 to 391,000 shares due to stock incentives [107]. - The company has a total of 342 employees with doctoral degrees and 2,193 with master's degrees [132]. - The company has established a dual career development path for management and technical positions, enhancing employee training and development [135]. Risk Management - The company faces risks including operational failures in clinical stage projects, lower-than-expected sales of innovative drugs, and potential impacts from international trade uncertainties and currency fluctuations [4]. - The company has established a derivative investment management system to control risks associated with derivative trading [85]. - The company has not reported any significant internal control deficiencies during the reporting period [150]. Community Engagement and Social Responsibility - The company has a long-standing commitment to social responsibility, focusing on quality products and services while pursuing sustainable development [155]. - The company actively participates in community support and social welfare initiatives, including funding for children with congenital heart disease [156]. - The company has contributed to rural revitalization efforts, including donations for infrastructure improvements in targeted villages [159].

南方电网数字电网研究院股份有限公司 2025 年年度报告全文 1 南方电网数字电网研究院股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律 责任。 公司负责人刘育权、主管会计工作负责人杜伟伦及会计机构负责人(会计 主管人员)欧阳欣声明：保证本年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次年报的董事会会议： | 未亲自出席董事 | 未亲自出席董事 | 未亲自出席会议 | 被委托人姓名 | | --- | --- | --- | --- | | 姓名 | 职务 | 原因 | | | 胡荣 | 董事 | 重要公务冲突 | 刘育权 | | 李志宏 | 独立董事 | 重要公务冲突 | 郭飞 | 本年度报告涉及的未来计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计 划、预测与承诺之间的差异。 本公司在本报告"第三节 管理层讨论与分析"之"十一、公司未来发 展 ...

公司代码：600493 公司简称：凤竹纺织 福建凤竹纺织科技股份有限公司 2025 年年度报告 福建凤竹纺织科技股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 华兴会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人陈强、主管会计工作负责人彭家国及会计机构负责人（会计主管人员）林勇声明： 保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2026 年 3 月 28 日公司召开第九届董事会第五次会议审议通过《公司 2025 年度利润分配的预 案》：经华兴会计师事务所（特殊普通合伙）审计，截至 2025 年 12 月 31 日，公司母公司报表期 末未分配利润为人民币 412,788,064.96 元。经董事会决议，公司 2025 年年度拟以实施权益分派 股权登记日登记的总股本为基数分配利润。本次利润分配方案如下： 1、公司拟向全体股东每股派发现 ...

Financial Performance - The company's operating revenue for 2025 reached RMB 1,451,059,622.81, representing a 1.31% increase compared to RMB 1,432,250,091.31 in 2024[24]. - The total profit for the year was RMB 43,863,218.64, a decrease of 32.52% from RMB 65,001,107.45 in the previous year[24]. - The net profit attributable to shareholders of the listed company was RMB 42,257,766.35, an increase of 4.45% from RMB 40,458,216.87 in 2024[24]. - The net cash flow from operating activities was RMB 158,941,554.33, showing a 9.78% increase from RMB 144,779,223.84 in 2024[24]. - The total assets at the end of 2025 were RMB 3,757,438,836.78, a decrease of 2.82% from RMB 3,866,610,548.61 at the end of 2024[24]. - The net assets attributable to shareholders of the listed company were RMB 2,495,436,185.17, reflecting a 1.80% increase from RMB 2,451,348,283.55 in 2024[24]. - Basic earnings per share for 2025 remained stable at CNY 0.04, compared to CNY 0.03 in 2023, reflecting no growth year-over-year[25]. - The weighted average return on equity increased to 1.71% in 2025, up by 0.06 percentage points from 1.65% in 2024[25]. - The company reported a net profit of RMB -16,297,455.69 after deducting non-recurring gains and losses, compared to RMB -40,987,036.30 in 2024[24]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 0.13 per 10 shares, totaling RMB 13,583,542.05 based on the total share capital of 1,044,887,850 shares[6]. - The cash dividend amount represents 32.14% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which is RMB 42,257,766.35[144]. - Over the last three accounting years, the cumulative cash dividend amount (including tax) is RMB 39,705,738.30, with a cash dividend ratio of 100.18% based on the average annual net profit of RMB 39,633,239.82[145]. - The company has not proposed a capital reserve transfer to increase share capital for the current year[141]. Operational Efficiency - The company initiated a comprehensive reform in late 2024, focusing on optimizing its structure and enhancing operational efficiency by consolidating management functions into seven efficient departments[41]. - The company is actively clearing low-efficiency operations, including the dissolution of a loss-making subsidiary, to ensure the proper disposal of state-owned assets[41]. - The company achieved operating revenue of ¥1,451,059,622.81, a year-on-year increase of 1.31%[53]. - Total profit amounted to ¥43,863,218.64, reflecting a year-on-year decline of 32.52%[53]. - Net profit attributable to shareholders was ¥42,257,766.35, showing a year-on-year increase of 4.45%[53]. Market and Industry Trends - The overall revenue of the A-share news and publishing industry decreased by 7.27% year-on-year to 93.901 billion yuan in the first three quarters of 2025, while net profit attributable to shareholders increased by 13.72% to 10.769 billion yuan[38]. - The overall retail market for books in 2025 saw a scale of 110.4 billion yuan, with a year-on-year decline of 2.24% in the nominal value and a 3.80% decrease in actual sales[38]. - The digital publishing market is expanding significantly, with notable growth in e-books, online literature, and knowledge payment sectors, while traditional publishing faces saturation issues[102]. Strategic Initiatives - The company aims to enhance its brand influence and operational quality by focusing on key publications, such as the issuance of "Xi Jinping: The Governance of China" Volume 5, with a comprehensive distribution network covering all 16 districts in Shanghai[45]. - The company launched the "Zhiyue Tong" AI learning tool, creating an integrated learning path that combines reading, practice, testing, and evaluation, aiming to foster a second growth curve in publishing business[48]. - The company is focusing on creating a competitive physical operation system by optimizing logistics and warehouse management for retail and educational materials[107]. - Future strategies include leveraging AI and MR technologies to transform from a traditional publisher to a K12 English learning service provider, enhancing digital transformation efforts[109]. Governance and Compliance - The company has established a performance evaluation and incentive mechanism for senior management, which includes annual target assessments based on financial and development quality indicators[147]. - The internal control audit report issued by the accounting firm indicates that the company maintained effective financial reporting internal controls as of December 31, 2025[148]. - The company has committed to maintaining independence from its controlling shareholders in terms of personnel, assets, and operations[116]. - The company has engaged in significant related party transactions, including a property lease with Shanghai Xinhua Distribution Group totaling RMB 2,100 million, with an actual settlement amount of RMB 1,937.72 million, representing 36.16% of similar transactions[165]. Employee and Management Structure - The company employed a total of 1,168 staff, including 628 sales personnel and 71 technical personnel[136]. - The compensation policy is based on a position-level salary system, with adjustments favoring mid to lower-level employees to enhance performance alignment with company goals[138]. - Total compensation for all directors and senior management at the end of the reporting period amounted to CNY 511.73 million[125]. Risks and Challenges - The company faces risks from new media impacting traditional book distribution and advertising, leading to downward pressure on physical bookstore operations[112]. - Changes in national tax policies could affect the company's profitability, as some subsidiaries currently benefit from tax exemptions[112]. - The company is undergoing a business transformation through internal development and external acquisitions, but new business models have not yet achieved scale[111].

信达证券股份有限公司2025 年年度报告 公司代码：601059 公司简称：信达证券 信达证券股份有限公司 2025 年年度报告 1 / 251 信达证券股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完整，不存在虚假记 载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人林志忠、主管会计工作负责人张毅及会计机构负责人（会计主管人员）刘晓乾 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司已实施2025年中期分红，分配方案为每10股派发现金红利人民币0.47元（含税），共计 人民币152,421,000元（含税）。公司2025年度利润分配预案：拟以实施权益分派股权登记日登记 的总股本为基数分配利润，向实施权益分派股权登记日登记在册的全体股东每10股派发现金红利 0.40元（含税）。 截至2026年3月30日，公司总股本3,243,000,000股，以此计 ...

Financial Performance - Total assets reached CNY 4.74 trillion, an increase of 8.25% compared to the end of the previous year[9]. - Total operating income for 2025 was CNY 91,914 million, a decrease of 5.39% compared to CNY 97,146 million in 2024[22]. - Net profit attributable to shareholders for 2025 was CNY 27,200 million, down 1.72% from CNY 27,676 million in 2024[22]. - The group's net profit for the reporting period was CNY 27.75 billion, a decrease of CNY 0.445 billion, or 1.58% year-on-year[61]. - The group's operating income was CNY 91.91 billion, with net interest income accounting for 68.49%[65]. - The group achieved interest income of CNY 135.15 billion, a decrease of CNY 11.33 billion or 7.74% year-on-year[69]. - The total tax expense for the year was CNY 6,423 million, down from CNY 7,683 million in the previous year[96]. Asset Quality - The non-performing loan ratio decreased by 0.05 percentage points compared to the end of the previous year, indicating improved asset quality[9]. - The non-performing loan ratio improved to 1.55%, down from 1.60% in 2024[22]. - The non-performing loan ratio was 1.55%, a decrease of 0.05 percentage points compared to the previous year, with non-performing loans totaling CNY 39.89 billion[130]. - The group maintained a stable loan quality, with the balance of attention loans increasing to CNY 68.58 billion, representing 2.67% of total loans[130]. Loan and Deposit Growth - The growth rate of both deposits and loans reached a five-year high, with technology finance loans increasing by 53.74% and green finance loans by 30.99%[10]. - The total loan amount rose by 8.47% to CNY 2,566,666 million compared to CNY 2,366,317 million in 2024[22]. - Total deposits increased to CNY 23,816.99 billion, reflecting a growth of CNY 2,303.29 billion or 10.71% from the previous year[48]. - Personal deposits grew by 9.01% year-over-year, while personal consumption loans increased by 0.40% and credit card issuance rose by 3.20%[37]. - Corporate deposits amounted to CNY 1,781.95 billion, an increase of 11.43% year-on-year, with an interest rate of 1.60%, down by 0.39 percentage points[180]. Digital Transformation and Innovation - The bank aims to enhance its digital banking capabilities and establish a comprehensive financial service ecosystem[15]. - The bank's digital transformation efforts included upgrading the mobile banking app and enhancing the digital operating management platform[39]. - The bank launched innovative products such as "Monthly Enjoy Deposit" to enhance customer experience and drive deposit growth[191]. - The bank's personal loan products underwent digital transformation, improving service efficiency and customer engagement[193]. - The number of clients served by the digital financial services reached 4,488, up by 78.02% year-on-year, with total financing of CNY 68.02 billion, a year-on-year increase of 227.55%[183]. Capital Adequacy and Liquidity - The core Tier 1 capital adequacy ratio was 9.38% at the end of 2023, exceeding the regulatory requirement of ≥7.75%[25]. - The Tier 1 capital adequacy ratio reached 11.75% at the end of 2023, above the regulatory minimum of ≥8.75%[25]. - The total capital adequacy ratio stood at 13.16% at the end of 2023, surpassing the required ≥10.75%[25]. - The liquidity coverage ratio was 154.93% at the end of 2023, well above the minimum requirement of ≥100%[25]. - The loan-to-deposit ratio in RMB was 90.60% at the end of 2023, indicating stable liquidity management[25]. Awards and Recognition - The bank received multiple awards in 2025, including "Best Supply Chain Financial Innovation Bank" and "Outstanding Wealth Management Bank"[27][28]. - The bank was ranked 47th globally in Tier 1 capital and 57th in total assets according to the Banker magazine's 2025 ranking[34]. Employee and Client Growth - The bank's employee count reached 36,200, supporting its extensive service capabilities across various financial products[34]. - Corporate clients increased by 6.72% year-over-year, with corporate deposits growing by 11.43% and company loans (excluding discounts) rising by 13.88%[36]. - The total number of retail customers reached 440.12 million, with private banking clients increasing by 21.71% to 520,200[189]. Wealth Management and Investment - Wealth management products balance increased by 45.82% year-over-year, and the bank's custody scale grew by 18.89%[38]. - The balance of sold corporate wealth management products reached CNY 107.04 billion, reflecting a year-on-year growth of 37.39%[187]. - The group issued CNY 100 billion in technology innovation bonds and CNY 200 billion in green financial bonds[49]. Strategic Focus - The bank is committed to deepening its service in key regions such as Beijing-Tianjin-Hebei and the Yangtze River Delta, enhancing its competitive advantage[13]. - The bank plans to focus on technology and green finance, building a specialized team for green financial services[15]. - The group continues to focus on supporting key sectors such as technology and green industries, while optimizing asset structure to manage risks effectively[134].

南京雷尔伟新技术股份有限公司 2025 年年度报告全文 南京雷尔伟新技术股份有限公司 2025 年年度报告 2026-003 2026 年 3 月 1 南京雷尔伟新技术股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律 责任。 公司负责人王冲、主管会计工作负责人陈娟及会计机构负责人(会计主管 人员)韩伟声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中如有涉及的未来发展规划、业绩预测等方面的内容，均不构成 公司对投资者的实质性承诺。投资者及相关人士均应对此保持足够的风险认 识，并应当理解计划、预测与承诺之间的差异。敬请广大投资者理性投资， 注意风险。 公司在经营中可能存在竞争加剧毛利率下降的风险、人力资源成本上升 带来的风险及产业政策变动的风险对公司经营业绩带来的风险。详情参见本 报告"第三节 管理层讨论与分析 十一、公司未来发展的展望"。敬请广大 投资者关注相关内容。 公司经本次董事会 ...

航天长征化学工程股份有限公司 2025 年年度报告 公司代码：603698 公司简称：航天工程 航天长征化学工程股份有限公司 2025 年年度报告 二、公司全体董事出席董事会会议。 三、大信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人姜从斌、主管会计工作负责人王光辉及会计机构负责人（会计主管人员）任民 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 1 / 197 航天长征化学工程股份有限公司 2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完整，不存在虚假记 载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司第五届董事会第十一次会议审议通过《关于公司2025年度利润分配方案的议案》，拟以 实施权益分派股权登记日登记的总股本为基数，每10股派发现金红利0.75元（含税）；截至2025 年12月31日，公司总股本53,599万股，以此计算拟派发现金红利40,199,250.00元（含税）。如在 实施权益分派的股权登记日前公司总股本发生变动的，拟维持每 ...

铜陵精达特种电磁线股份有限公司2025 年年度报告 公司代码：600577 公司简称：精达股份 铜陵精达特种电磁线股份有限公司 2025 年年度报告 1 铜陵精达特种电磁线股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 容诚会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人李晓、主管会计工作负责人张军强及会计机构负责人（会计主管人员）张军强 声明：保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 经容诚会计师事务所（特殊普通合伙）审计，铜陵精达特种电磁线股份有限公司（以下简称 "公司"）本部2025年1－12月实现净利润264,398,949.48元，2025年度利润分配预案为： 1、按10%提取法定盈余公积金26,439,894.95元。 2、扣除1项后本期未分配利润为237,959,054.53元，加上年初未分配利润503,765,1 ...